We are live on ! Find out more
FCE

Fiera Capital (Europe) Portfolio holdings

AUM $213M
1-Year Est. Return 42.35%
This Fund
S&P 500
This Quarter Est. Return
-0.28%
1 Year Est. Return
+42.35%
3 Year Est. Return
+41.33%
5 Year Est. Return
10 Year Est. Return
AUM
$110M
AUM Growth
-$351K
Cap. Flow
+$17.2M
Cap. Flow %
15.66%
Top 10 Hldgs %
79.49%
Holding
54
New
6
Increased
3
Reduced
22
Closed
4

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$7.61M
2
ITUB icon
Itaú Unibanco
ITUB
+$6.83M
3
LXFT
Luxoft Holding, Inc.
LXFT
+$3.77M
4
ABEV icon
Ambev
ABEV
+$2.14M
5
FMX icon
Fomento Económico Mexicano
FMX
+$1.63M

Sector Composition

Rank Sector Weight
1 Communication Services 37.48%
2 Financials 17.29%
3 Consumer Staples 17.1%
4 Materials 10.54%
5 Consumer Discretionary 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$220B
$262K 0.24%
2,020
BMA icon
27
Banco Macro
BMA
$5.35B
$252K 0.23%
5,495
AMGN icon
28
Amgen
AMGN
$222B
$251K 0.23%
1,633
CZZ
29
DELISTED
Cosan Limited
CZZ
$241K 0.22%
39,189
-8,609
-18% -$58.9K
UNH icon
30
UnitedHealth
UNH
$370B
$228K 0.21%
+1,864
New +$220K
CVS icon
31
CVS Health
CVS
$122B
$217K 0.2%
2,068
ILMN icon
32
Illumina
ILMN
$28.4B
$207K 0.19%
975
BMY icon
33
Bristol-Myers Squibb
BMY
$132B
$202K 0.18%
3,032
-678
-18% -$44.7K
MDVN
34
DELISTED
MEDIVATION, INC.
MDVN
$184K 0.17%
3,226
+16
+0.5% +$986
IPXL
35
DELISTED
Impax Laboratories, Inc.
IPXL
$181K 0.16%
3,949
REGN icon
36
Regeneron Pharmaceuticals
REGN
$80.8B
$174K 0.16%
341
AMPH icon
37
Amphastar Pharmaceuticals
AMPH
$916M
$149K 0.14%
8,451
BDX icon
38
Becton Dickinson
BDX
$48.2B
$149K 0.14%
1,076
VALE icon
39
Vale
VALE
$62.6B
$145K 0.13%
24,782
-13,629
-35% -$91.3K
BSX icon
40
Boston Scientific
BSX
$71.5B
$136K 0.12%
7,675
ABT icon
41
Abbott
ABT
$187B
$115K 0.1%
2,339
CELG
42
DELISTED
Celgene Corp
CELG
$105K 0.1%
908
SYK icon
43
Stryker
SYK
$130B
$100K 0.09%
1,047
EW icon
44
Edwards Lifesciences
EW
$51.7B
$93K 0.08%
3,924
INCY icon
45
Incyte
INCY
$24.4B
$89K 0.08%
857
AEGR
46
DELISTED
Aegerion Pharmaceuticals
AEGR
$83K 0.08%
4,362
-5,279
-55% -$114K
CAH icon
47
Cardinal Health
CAH
$55.4B
$82K 0.07%
981
IQV icon
48
IQVIA
IQV
$39.3B
$71K 0.06%
973
IRWD icon
49
Ironwood Pharmaceuticals
IRWD
$714M
$67K 0.06%
+6,663
New +$77.4K
BIIB icon
50
Biogen
BIIB
$30.7B
$44K 0.04%
108
-108
-50% -$43.3K

Similar funds

Fiera Capital (Europe)'s Q2 2015 Portfolio in Review

As of Q2 2015, Fiera Capital (Europe) held 54 positions worth $110M, down 0.32% from $110M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Fiera Capital (Europe) deployed $17.2M of net new capital in Q2 2015, opening 6 new positions and adding to 3 existing holdings. Its largest new stake was Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares: 1,814,651 shares worth $17.7M.

By sector, the portfolio is most concentrated in Communication Services at 37% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was JD.com, an estimated $7.61M trimmed.

  • Fiera Capital (Europe)'s largest Q2 2015 buy was Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares: 1,814,651 shares worth $17.7M.
  • Fiera Capital (Europe) added most to Baidu in Q2 2015, an estimated $18.3M increase.
  • Fiera Capital (Europe)'s biggest Q2 2015 reduction was JD.com, cutting an estimated $7.61M.
  • Fiera Capital (Europe) fully exited AVIANCA HOLDINGS S.A. in Q2 2015, selling an estimated $1.41M.
  • Fiera Capital (Europe)'s ten largest holdings make up 79% of its $110M portfolio in Q2 2015.
  • Fiera Capital (Europe) opened 6 new positions and closed 4 in Q2 2015.
  • Fiera Capital (Europe)'s portfolio value fell 0.32% quarter-over-quarter to $110M.

Based on Fiera Capital (Europe)'s 13F filing for Q2 2015, filed 11 Aug 2015.